secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vistagen Therapeutics, Inc. (VTGN)
CIK:        0001411685
Form:       8-K
Filed at:   2026-01-09T23:59:59+00:00
Accession:  0001628280-26-001690
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vistagen releases corporate presentation highlighting nose-to-brain neuroscience platform
--------------------------------------------------------------------------------

- Presentation dated January 2026 describes nose-to-brain neurocircuitry for CNS disorders.
- No financial data, pipeline updates, or milestones disclosed in the filing excerpt.
- VTGN common stock trades on Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1411685/000162828026001690/0001628280-26-001690-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1411685/000162828026001690/vtgn-20260109.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-001690

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer